These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37399765)

  • 1. Clinical response to treatment with a partial dopamine agonist is related to changes in reward processing.
    Tangmose K; Rostrup E; Bojesen KB; Sigvard A; Glenthøj BY; Nielsen MØ
    Psychiatry Res; 2023 Aug; 326():115308. PubMed ID: 37399765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reward disturbances in antipsychotic-naïve patients with first-episode psychosis and their association to glutamate levels.
    Tangmose K; Rostrup E; Bojesen KB; Sigvard A; Jessen K; Johansen LB; Glenthøj BY; Nielsen MØ
    Psychol Med; 2023 Mar; 53(4):1629-1638. PubMed ID: 37010221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation between dopamine D
    Wulff S; Nielsen MØ; Rostrup E; Svarer C; Jensen LT; Pinborg L; Glenthøj BY
    Psychol Med; 2020 Jan; 50(2):220-228. PubMed ID: 30642415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of motivational salience processing during the early stages of psychosis.
    Smieskova R; Roiser JP; Chaddock CA; Schmidt A; Harrisberger F; Bendfeldt K; Simon A; Walter A; Fusar-Poli P; McGuire PK; Lang UE; Riecher-Rössler A; Borgwardt S
    Schizophr Res; 2015 Aug; 166(1-3):17-23. PubMed ID: 25999039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain responses to different types of salience in antipsychotic naïve first episode psychosis: An fMRI study.
    Knolle F; Ermakova AO; Justicia A; Fletcher PC; Bunzeck N; Düzel E; Murray GK
    Transl Psychiatry; 2018 Sep; 8(1):196. PubMed ID: 30242202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic Activity in Antipsychotic-Naïve Patients Assessed With Positron Emission Tomography Before and After Partial Dopamine D
    Sigvard AK; Nielsen MØ; Gjedde A; Bojesen KB; Fuglø D; Tangmose K; Kumakura Y; Heltø K; Ebdrup BH; Jensen LT; Rostrup E; Glenthøj BY
    Biol Psychiatry; 2022 Jan; 91(2):236-245. PubMed ID: 34743917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How antipsychotics become anti-"psychotic"--from dopamine to salience to psychosis.
    Kapur S
    Trends Pharmacol Sci; 2004 Aug; 25(8):402-6. PubMed ID: 15276708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative Symptoms and Reward Disturbances in Schizophrenia Before and After Antipsychotic Monotherapy.
    Nielsen MØ; Rostrup E; Broberg BV; Wulff S; Glenthøj B
    Clin EEG Neurosci; 2018 Jan; 49(1):36-45. PubMed ID: 29145751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia.
    Nielsen MO; Rostrup E; Wulff S; Bak N; Broberg BV; Lublin H; Kapur S; Glenthoj B
    Arch Gen Psychiatry; 2012 Dec; 69(12):1195-204. PubMed ID: 22868877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine partial agonists: a new class of antipsychotic.
    Lieberman JA
    CNS Drugs; 2004; 18(4):251-67. PubMed ID: 15015905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dopamine agonists on adaptive and aberrant salience in Parkinson's disease.
    Nagy H; Levy-Gigi E; Somlai Z; Takáts A; Bereczki D; Kéri S
    Neuropsychopharmacology; 2012 Mar; 37(4):950-8. PubMed ID: 22089321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficits in context-dependent adaptive coding in early psychosis and healthy individuals with schizotypal personality traits.
    Kirschner M; Haugg A; Manoliu A; Simon JJ; Huys QJM; Seifritz E; Tobler PN; Kaiser S
    Brain; 2018 Sep; 141(9):2806-2819. PubMed ID: 30169587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis.
    Wilson R; Bossong MG; Appiah-Kusi E; Petros N; Brammer M; Perez J; Allen P; McGuire P; Bhattacharyya S
    Transl Psychiatry; 2019 Aug; 9(1):203. PubMed ID: 31439831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of a dopaminergic modulation fMRI task by amisulpride and L-DOPA on reward anticipation in healthy volunteers.
    Grimm O; Nägele M; Küpper-Tetzel L; de Greck M; Plichta M; Reif A
    Psychopharmacology (Berl); 2021 May; 238(5):1333-1342. PubMed ID: 33140215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis.
    Gunasekera B; Wilson R; O'Neill A; Blest-Hopley G; O'Daly O; Bhattacharyya S
    Psychol Med; 2023 Jul; 53(10):4732-4741. PubMed ID: 35775365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson's disease.
    van der Vegt JPM; Hulme OJ; Madsen KH; Buhmann C; Bloem BR; Münchau A; Helmich RC; Siebner HR
    Neuroimage Clin; 2020; 28():102362. PubMed ID: 32798910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
    Ebdrup BH; Raghava JM; Nielsen MØ; Rostrup E; Glenthøj B
    J Psychiatry Neurosci; 2016 Mar; 41(2):133-41. PubMed ID: 26599135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia.
    Arce E; Balice-Gordon R; Duvvuri S; Naylor M; Xie Z; Harel B; Kozak R; Gray DL; DeMartinis N
    J Psychopharmacol; 2019 Oct; 33(10):1237-1247. PubMed ID: 31264510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the brain reward system in antipsychotic naïve schizophrenia patients.
    Nielsen MØ; Rostrup E; Wulff S; Bak N; Lublin H; Kapur S; Glenthøj B
    Biol Psychiatry; 2012 May; 71(10):898-905. PubMed ID: 22418013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis.
    Schmidt A; Antoniades M; Allen P; Egerton A; Chaddock CA; Borgwardt S; Fusar-Poli P; Roiser JP; Howes O; McGuire P
    Psychol Med; 2017 Jan; 47(2):243-254. PubMed ID: 27697078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.